Consequences of menopause in women with diabetes mellitus - a clinical problem

被引:7
作者
Jedrzejuk, D [1 ]
Milewicz, A [1 ]
机构
[1] Wroclaw Med Univ, Dept Endocrinol Diabetol & Isotpoe Therapy, PL-50367 Wroclaw, Poland
关键词
menopause; diabetes mellitus;
D O I
10.1080/09513590500378964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human life was prolonged by 30 years in the past century, with the result that about 40% of a woman's life falls within the postmenopausal period. The consequences, both early and remote, in the form of cardiovascular disease, osteoporosis and neoplastic disease are most pronounced in women suffering from one of the most common diseases, i.e., diabetes mellitus and the metabolic syndrome preceding it. These patients are problematic for physicians, and for this reason a study of diagnostic and therapeutic management was undertaken on the basis of our own experience as well as examination based on evidence-based medicine. Prior to making therapeutic decisions it is necessary to determine cardiovascular, thromboembolic and breast cancer risk factors. Hormonal therapy may be helpful in young postmenopausal women who are free of risk factors, and its composition and route of administration are significant considerations. Women with risk factors and who are more than 10 years after menopause should be administered alternative therapy depending on the diagnosed pathology.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 67 条
[1]  
ABRAHAM WT, 2004, AM J MED S5A, V8, pS39
[2]   Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements [J].
Akin, O ;
Göl, K ;
Aktürk, M ;
Erkaya, S .
GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (01) :19-29
[3]   Smoking and mortality among women with type 2 diabetes - The Nurses' Health Study cohort [J].
Al-Delaimy, WK ;
Willett, WC ;
Manson, JE ;
Speizer, FE ;
Hu, FB .
DIABETES CARE, 2001, 24 (12) :2043-2048
[4]   Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women [J].
Bottini, N ;
MacMurray, J ;
Peters, W ;
Rostamkhani, M ;
Comings, DE .
MOLECULAR GENETICS AND METABOLISM, 2002, 77 (03) :226-229
[5]  
*CEP, 2001, JAMA-J AM MED ASSOC, V285, P2486
[6]   Metabolic and behavioral characteristics of metabolically obese but normal-weight women [J].
Conus, F ;
Allison, DB ;
Rabasa-Lhoret, R ;
St-Onge, M ;
St-Pierre, DH ;
Tremblay-Lebeau, A ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :5013-5020
[7]   Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women [J].
Crespo, CJ ;
Smit, E ;
Snelling, A ;
Sempos, CT ;
Andersen, RE .
DIABETES CARE, 2002, 25 (10) :1675-1680
[8]   Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: Effects on serum lipoproteins and glucose tolerance during 24 month follow up [J].
Crook, D ;
Godsland, IF ;
Hull, J ;
Stevenson, JC .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03) :298-304
[9]   Circulating adiponectin and endometrial cancer risk [J].
Dal Maso, L ;
Augustin, LSA ;
Karalis, A ;
Talamini, R ;
Franceschi, S ;
Trichopoulos, D ;
Mantzoros, CS ;
La Vecchia, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1160-1163
[10]   Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women [J].
Deng, HW ;
Li, J ;
Li, JL ;
Dowd, R ;
Davies, KM ;
Johnson, M ;
Gong, G ;
Deng, HY ;
Recker, RR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2748-2751